{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:38:18Z","timestamp":1780925898077,"version":"3.54.1"},"publisher-location":"Cham","reference-count":157,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031268588","type":"print"},{"value":"9783031268595","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/164_2022_618","type":"book-chapter","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T05:02:51Z","timestamp":1667278971000},"page":"209-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["NMR-Based Metabolomics to Evaluate Individual Response to Treatments"],"prefix":"10.1007","author":[{"given":"Alessia","family":"Vignoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Meoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Tenori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Turano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"618_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1164\/rccm.2108013","volume":"166","author":"AG Agusti","year":"2002","unstructured":"Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X (2002) Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:485\u2013489. https:\/\/doi.org\/10.1164\/rccm.2108013","journal-title":"Am J Respir Crit Care Med"},{"key":"618_CR2","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1021\/acs.jproteome.6b00648","volume":"15","author":"C Airoldi","year":"2016","unstructured":"Airoldi C, Ciaramelli C, Fumagalli M, Bussei R, Mazzoni V, Viglio S, Iadarola P, Stolk J (2016) 1H NMR To explore the metabolome of exhaled breath condensate in \u03b11-antitrypsin deficient patients: a pilot study. J Proteome Res 15:4569\u20134578. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00648","journal-title":"J Proteome Res"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1021\/pr400964s","volume":"13","author":"M-BS Andersen","year":"2014","unstructured":"Andersen M-BS, Rinnan \u00c5, Manach C, Poulsen SK, Pujos-Guillot E, Larsen TM, Astrup A, Dragsted LO (2014) Untargeted metabolomics as a screening tool for estimating compliance to a dietary pattern. J Proteome Res 13:1405\u20131418. https:\/\/doi.org\/10.1021\/pr400964s","journal-title":"J Proteome Res"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0060-y","volume":"50","author":"MR Antoniewicz","year":"2018","unstructured":"Antoniewicz MR (2018) A guide to 13C metabolic flux analysis for the cancer biologist. Exp Mol Med 50:1\u201313. https:\/\/doi.org\/10.1038\/s12276-018-0060-y","journal-title":"Exp Mol Med"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-10-1319","volume":"70","author":"VM Asiago","year":"2010","unstructured":"Asiago VM, Alvarado LZ, Shanaiah N, Gowda GAN, Owusu-Sarfo K, Ballas RA, Raftery D (2010) Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 70:8309\u20138318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1319","journal-title":"Cancer Res"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1073\/pnas.0705685105","volume":"105","author":"M Assfalg","year":"2008","unstructured":"Assfalg M, Bertini I, Colangiuli D, Luchinat C, Sch\u00e4fer H, Sch\u00fctz B, Spraul M (2008) Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci U S A 105:1420\u20131424. https:\/\/doi.org\/10.1073\/pnas.0705685105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","volume":"84","author":"IA Ayta","year":"1999","unstructured":"Ayta IA, McKinlay JB, Krane RJ (1999) The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 84:50\u201356. https:\/\/doi.org\/10.1046\/j.1464-410x.1999.00142.x","journal-title":"BJU Int"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/biomedicines9091090","volume":"9","author":"RA Ballout","year":"2021","unstructured":"Ballout RA, Kong H, Sampson M, Otvos JD, Cox AL, Agbor-Enoh S, Remaley AT (2021) The NIH Lipo-COVID study: a pilot NMR investigation of lipoprotein subfractions and other metabolites in patients with severe COVID-19. Biomedicine 9:1090. https:\/\/doi.org\/10.3390\/biomedicines9091090","journal-title":"Biomedicine"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.3390\/app11094231","volume":"11","author":"E Baranovicova","year":"2021","unstructured":"Baranovicova E, Bobcakova A, Vysehradsky R, Dankova Z, Halasova E, Nosal V, Lehotsky J (2021) The ability to normalise energy metabolism in advanced COVID-19 disease seems to be one of the key factors determining the disease progression \u2013 a metabolomic NMR study on blood plasma. Appl Sci 11:4231. https:\/\/doi.org\/10.3390\/app11094231","journal-title":"Appl Sci"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM200007273430407","volume":"343","author":"PJ Barnes","year":"2000","unstructured":"Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:269\u2013280. https:\/\/doi.org\/10.1056\/NEJM200007273430407","journal-title":"N Engl J Med"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"13025","DOI":"10.1038\/s41598-021-92508-1","volume":"11","author":"B Bendinelli","year":"2021","unstructured":"Bendinelli B, Vignoli A, Palli D, Assedi M, Ambrogetti D, Luchinat C, Caini S, Saieva C, Turano P, Masala G (2021) Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density. Sci Rep 11:13025. https:\/\/doi.org\/10.1038\/s41598-021-92508-1","journal-title":"Sci Rep"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/pr100896s","volume":"10","author":"P Bernini","year":"2011","unstructured":"Bernini P, Bertini I, Calabr\u00f2 A, la Marca G, Lami G, Luchinat C, Renzi D, Tenori L (2011a) Are patients with potential celiac disease really potential? The answer of metabonomics. J Proteome Res 10:714\u2013721. https:\/\/doi.org\/10.1021\/pr100896s","journal-title":"J Proteome Res"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1021\/pr200452j","volume":"10","author":"P Bernini","year":"2011","unstructured":"Bernini P, Bertini I, Luchinat C, Tenori L, Tognaccini A (2011b) The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples. J Proteome Res 10:4983\u20134992. https:\/\/doi.org\/10.1021\/pr200452j","journal-title":"J Proteome Res"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/0008-5472-11-1543","volume":"72","author":"I Bertini","year":"2012","unstructured":"Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruh\u00f8ffer M, Luchinat C, Nielsen DL, Turano P (2012) Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 72:356\u2013364. https:\/\/doi.org\/10.1158\/0008-5472-11-1543","journal-title":"Cancer Res"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/pr800548z","volume":"8","author":"I Bertini","year":"2009","unstructured":"Bertini I, Calabr\u00f2 A, De Carli V, Luchinat C, Nepi S, Porfirio B, Renzi D, Saccenti E, Tenori L (2009) The metabonomic signature of celiac disease. J Proteome Res 8:170\u2013177. https:\/\/doi.org\/10.1021\/pr800548z","journal-title":"J Proteome Res"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11306-013-0572-3","volume":"10","author":"I Bertini","year":"2014","unstructured":"Bertini I, Luchinat C, Miniati M, Monti S, Tenori L (2014) Phenotyping COPD by H-1 NMR metabolomics of exhaled breath condensate. Metabolomics 10:302\u2013311. https:\/\/doi.org\/10.1007\/s11306-013-0572-3","journal-title":"Metabolomics"},{"key":"618_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4637","volume":"35","author":"M Bizkarguenaga","year":"2021","unstructured":"Bizkarguenaga M, Bruzzone C, Gil-Redondo R, SanJuan I, Martin-Ruiz I, Barriales D, Palacios A, Pasco ST, Gonz\u00e1lez-Valle B, La\u00edn A, Herrera L, Azkarate A, Vesga MA, Eguizabal C, Anguita J, Embade N, Mato JM, Millet O (2021) Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR Biomed 35:e4637. https:\/\/doi.org\/10.1002\/nbm.4637","journal-title":"NMR Biomed"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlh\u00e4ufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crin\u00f2 L, Blumenschein GR, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373:1627\u20131639. https:\/\/doi.org\/10.1056\/NEJMoa1507643","journal-title":"N Engl J Med"},{"key":"618_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/j.seminoncol.2013.12.014","volume":"41","author":"JR Brahmer","year":"2014","unstructured":"Brahmer JR (2014) Immune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer? Semin Oncol 41:126\u2013132. https:\/\/doi.org\/10.1053\/j.seminoncol.2013.12.014","journal-title":"Semin Oncol"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.isci.2020.101645","volume":"23","author":"C Bruzzone","year":"2020","unstructured":"Bruzzone C, Bizkarguenaga M, Gil-Redondo R, Diercks T, Arana E, Garc\u00eda de Vicu\u00f1a A, Seco M, Bosch A, Palaz\u00f3n A, San Juan I, La\u00edn A, Gil-Mart\u00ednez J, Bernardo-Seisdedos G, Fern\u00e1ndez-Ramos D, Lopitz-Otsoa F, Embade N, Lu S, Mato JM, Millet O (2020) SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience 23:101645. https:\/\/doi.org\/10.1016\/j.isci.2020.101645","journal-title":"iScience"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.amjmed.2008.09.041","volume":"122","author":"H Buchwald","year":"2009","unstructured":"Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248\u2013256.e5. https:\/\/doi.org\/10.1016\/j.amjmed.2008.09.041","journal-title":"Am J Med"},{"key":"618_CR22","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1021\/pr400702d","volume":"12","author":"S Cacciatore","year":"2013","unstructured":"Cacciatore S, Hu X, Viertler C, Kap M, Bernhardt GA, Mischinger H-J, Riegman P, Zatloukal K, Luchinat C, Turano P (2013) Effects of intra- and post-operative ischemia on the metabolic profile of clinical liver tissue specimens monitored by NMR. J Proteome Res 12:5723\u20135729. https:\/\/doi.org\/10.1021\/pr400702d","journal-title":"J Proteome Res"},{"key":"618_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190958","volume":"13","author":"MP Cala","year":"2018","unstructured":"Cala MP, Aldana J, Medina J, S\u00e1nchez J, Guio J, Wist J, Meesters RJW (2018) Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: a pilot control-case study in Colombian Hispanic women. PLoS One 13:e0190958. https:\/\/doi.org\/10.1371\/journal.pone.0190958","journal-title":"PLoS One"},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"10497","DOI":"10.1038\/s41598-017-10807-y","volume":"7","author":"A Cano","year":"2017","unstructured":"Cano A, Mari\u00f1o Z, Millet O, Mart\u00ednez-Arranz I, Navasa M, Falc\u00f3n-P\u00e9rez JM, P\u00e9rez-Cormenzana M, Caballer\u00eda J, Embade N, Forns X, Bosch J, Castro A, Mato JM (2017) A metabolomics signature linked to liver fibrosis in the serum of transplanted hepatitis C patients. Sci Rep 7:10497. https:\/\/doi.org\/10.1038\/s41598-017-10807-y","journal-title":"Sci Rep"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.bbadis.2014.07.018","volume":"1842","author":"P-A Chen","year":"2014","unstructured":"Chen P-A, Xu Z-H, Huang Y-L, Luo Y, Zhu D-J, Wang P, Du Z-Y, Yang Y, Wu D-H, Lai W-Y, Ren H, Xu D-L (2014) Increased serum 2-oxoglutarate associated with high myocardial energy expenditure and poor prognosis in chronic heart failure patients. Biochim Biophys Acta 1842:2120\u20132125. https:\/\/doi.org\/10.1016\/j.bbadis.2014.07.018","journal-title":"Biochim Biophys Acta"},{"key":"618_CR26","doi-asserted-by":"publisher","first-page":"e83866","DOI":"10.1371\/journal.pone.0083866","volume":"8","author":"JS Choi","year":"2013","unstructured":"Choi JS, Baek H-M, Kim S, Kim MJ, Youk JH, Moon HJ, Kim E-K, Nam YK (2013) Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy. PLoS One 8:e83866. https:\/\/doi.org\/10.1371\/journal.pone.0083866","journal-title":"PLoS One"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/toxsci\/kfs230","volume":"132","author":"L Choucha Snouber","year":"2013","unstructured":"Choucha Snouber L, Bunescu A, Naudot M, Legallais C, Brochot C, Dumas ME, Elena-Herrmann B, Leclerc E (2013) Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and its active metabolite hydroxyflutamide using HepG2\/C3a microfluidic biochips. Toxicol Sci 132:8\u201320. https:\/\/doi.org\/10.1093\/toxsci\/kfs230","journal-title":"Toxicol Sci"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.3390\/cancers13225845","volume":"13","author":"G Corona","year":"2021","unstructured":"Corona G, Di Gregorio E, Vignoli A, Muraro E, Steffan A, Miolo G (2021) 1H-NMR plasma lipoproteins profile analysis reveals lipid metabolism alterations in HER2-positive breast cancer patients. Cancers 13:5845. https:\/\/doi.org\/10.3390\/cancers13225845","journal-title":"Cancers"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/andr.12255","volume":"4","author":"G Corona","year":"2016","unstructured":"Corona G, Rastrelli G, Burri A, Serra E, Gianfrilli D, Mannucci E, Jannini EA, Maggi M (2016) First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology 4:1002\u20131009. https:\/\/doi.org\/10.1111\/andr.12255","journal-title":"Andrology"},{"key":"618_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","volume":"375","author":"D Cunningham","year":"2010","unstructured":"Cunningham D, Atkin W, Lenz H-J, Lynch HT, Minsky B, Nordlinger B, Starling N (2010) Colorectal cancer. Lancet 375:1030\u20131047. https:\/\/doi.org\/10.1016\/S0140-6736(10)60353-4","journal-title":"Lancet"},{"key":"618_CR31","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1074\/jbc.M111.337196","volume":"287","author":"M Cuperlovic-Culf","year":"2012","unstructured":"Cuperlovic-Culf M, Ferguson D, Culf A, Morin P, Touaibia M (2012) 1H NMR metabolomics analysis of glioblastoma subtypes correlation between metabolomics and gene expression characteristics. J Biol Chem 287:20164\u201320175. https:\/\/doi.org\/10.1074\/jbc.M111.337196","journal-title":"J Biol Chem"},{"key":"618_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12964-019-0421-8","volume":"17","author":"G D\u2019Alessandro","year":"2019","unstructured":"D\u2019Alessandro G, Quaglio D, Monaco L, Lauro C, Ghirga F, Ingallina C, De Martino M, Fucile S, Porzia A, Di Castro MA, Bellato F, Mastrotto F, Mori M, Infante P, Turano P, Salmaso S, Caliceti P, Di Marcotullio L, Botta B, Ghini V, Limatola C (2019) 1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma. Cell Commun Signal 17:108. https:\/\/doi.org\/10.1186\/s12964-019-0421-8","journal-title":"Cell Commun Signal"},{"key":"618_CR33","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/acs.jproteome.9b00316","volume":"18","author":"J Debik","year":"2019","unstructured":"Debik J, Euceda LR, Lundgren S, Gythfeldt H v d L, Garred \u00d8, Borgen E, Engebraaten O, Bathen TF, Giske\u00f8deg\u00e5rd GF (2019) Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients. J Proteome Res 18:3649\u20133660. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00316","journal-title":"J Proteome Res"},{"key":"618_CR34","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394:1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"Lancet"},{"key":"618_CR35","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.3390\/cancers13112762","volume":"13","author":"S Di Donato","year":"2021","unstructured":"Di Donato S, Vignoli A, Biagioni C, Malorni L, Mori E, Tenori L, Calamai V, Parnofiello A, Di Pierro G, Migliaccio I, Cantafio S, Baraghini M, Mottino G, Becheri D, Del Monte F, Miceli E, McCartney A, Di Leo A, Luchinat C, Biganzoli L (2021) A serum metabolomics classifier derived from elderly patients with metastatic colorectal cancer predicts relapse in the adjuvant setting. Cancers 13:2762. https:\/\/doi.org\/10.3390\/cancers13112762","journal-title":"Cancers"},{"key":"618_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/cancers13010147","volume":"13","author":"L D\u00edaz-Beltr\u00e1n","year":"2021","unstructured":"D\u00edaz-Beltr\u00e1n L, Gonz\u00e1lez-Olmedo C, Luque-Caro N, D\u00edaz C, Mart\u00edn-Bl\u00e1zquez A, Fern\u00e1ndez-Navarro M, Ortega-Granados AL, G\u00e1lvez-Montosa F, Vicente F, P\u00e9rez del Palacio J, S\u00e1nchez-Rovira P (2021) Human plasma metabolomics for biomarker discovery: targeting the molecular subtypes in breast cancer. Cancers 13:147. https:\/\/doi.org\/10.3390\/cancers13010147","journal-title":"Cancers"},{"key":"618_CR37","doi-asserted-by":"publisher","first-page":"e88102","DOI":"10.1371\/journal.pone.0088102","volume":"9","author":"Z Du","year":"2014","unstructured":"Du Z, Shen A, Huang Y, Su L, Lai W, Wang P, Xie Z, Xie Z, Zeng Q, Ren H, Xu D (2014) 1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients. PLoS One 9:e88102. https:\/\/doi.org\/10.1371\/journal.pone.0088102","journal-title":"PLoS One"},{"key":"618_CR38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3892\/mco.2017.1407","volume":"7","author":"MA Dykstra","year":"2017","unstructured":"Dykstra MA, Switzer N, Eisner R, Tso V, Foshaug R, Ismond K, Fedorak R, Wang H (2017) Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer. Mol Clin Oncol 7:767\u2013770. https:\/\/doi.org\/10.3892\/mco.2017.1407","journal-title":"Mol Clin Oncol"},{"key":"618_CR39","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717. https:\/\/doi.org\/10.1016\/S0140-6736(05)66544-0","journal-title":"Lancet"},{"key":"618_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11306-017-1168-0","volume":"13","author":"LR Euceda","year":"2017","unstructured":"Euceda LR, Haukaas TH, Giske\u00f8deg\u00e5rd GF, Vettukattil MR, Engel J, Silwal-Pandit L, Lundgren S, Borgen E, Garred \u00d8, Postma G, Buydens LMC, B\u00f8rresen-Dale A-L, Engebr\u00e5ten O, Bathen TF (2017) Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics 13:37. https:\/\/doi.org\/10.1007\/s11306-017-1168-0","journal-title":"Metabolomics"},{"key":"618_CR41","doi-asserted-by":"publisher","first-page":"9925","DOI":"10.18632\/oncotarget.7155","volume":"7","author":"Y Fan","year":"2016","unstructured":"Fan Y, Zhou X, Xia T-S, Chen Z, Li J, Liu Q, Alolga RN, Chen Y, Lai M-D, Li P, Zhu W, Qi L-W (2016) Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer. Oncotarget 7:9925\u20139938. https:\/\/doi.org\/10.18632\/oncotarget.7155","journal-title":"Oncotarget"},{"key":"618_CR42","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY-S, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC, KEYNOTE-189 Investigators (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378:2078\u20132092. https:\/\/doi.org\/10.1056\/NEJMoa1801005","journal-title":"N Engl J Med"},{"key":"618_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1021\/tx0498915","volume":"18","author":"S Garrod","year":"2005","unstructured":"Garrod S, Bollard ME, Nicholls AW, Connor SC, Connelly J, Nicholson JK, Holmes E (2005) Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chem Res Toxicol 18:115\u2013122. https:\/\/doi.org\/10.1021\/tx0498915","journal-title":"Chem Res Toxicol"},{"key":"618_CR44","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1200\/JCO.2014.58.3708","volume":"33","author":"SN Gettinger","year":"2015","unstructured":"Gettinger SN, Horn L, Gandhi L, Spigel DR, Antonia SJ, Rizvi NA, Powderly JD, Heist RS, Carvajal RD, Jackman DM, Sequist LV, Smith DC, Leming P, Carbone DP, Pinder-Schenck MC, Topalian SL, Hodi FS, Sosman JA, Sznol M, McDermott DF, Pardoll DM, Sankar V, Ahlers CM, Salvati M, Wigginton JM, Hellmann MD, Kollia GD, Gupta AK, Brahmer JR (2015) Overall survival and long-term safety of nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer. J Clin Oncol 33:2004\u20132012. https:\/\/doi.org\/10.1200\/JCO.2014.58.3708","journal-title":"J Clin Oncol"},{"key":"618_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/ijms18020359","volume":"18","author":"V Ghini","year":"2017","unstructured":"Ghini V, Di Nunzio M, Tenori L, Valli V, Danesi F, Capozzi F, Luchinat C, Bordoni A (2017) Evidence of a DHA signature in the lipidome and metabolome of human hepatocytes. Int J Mol Sci 18:359. https:\/\/doi.org\/10.3390\/ijms18020359","journal-title":"Int J Mol Sci"},{"key":"618_CR46","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.3390\/cancers12123574","volume":"12","author":"V Ghini","year":"2020","unstructured":"Ghini V, Laera L, Fantechi B, del Monte F, Benelli M, McCartney A, Tenori L, Luchinat C, Pozzessere D (2020a) Metabolomics to assess response to immune checkpoint inhibitors in patients with non-small-cell lung cancer. Cancers 12:3574. https:\/\/doi.org\/10.3390\/cancers12123574","journal-title":"Cancers"},{"key":"618_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.839809","volume":"9","author":"V Ghini","year":"2022","unstructured":"Ghini V, Maggi L, Mazzoni A, Spinicci M, Zammarchi L, Bartoloni A, Annunziato F, Turano P (2022a) Serum NMR profiling reveals differential alterations in the lipoproteome induced by Pfizer-BioNTech vaccine in COVID-19 recovered subjects and Na\u00efve subjects. Front Mol Biosci 9:839809. https:\/\/doi.org\/10.3389\/fmolb.2022.839809","journal-title":"Front Mol Biosci"},{"key":"618_CR48","doi-asserted-by":"publisher","first-page":"e1010443","DOI":"10.1371\/journal.ppat.1010443","volume":"18","author":"V Ghini","year":"2022","unstructured":"Ghini V, Meoni G, Pelagatti L, Celli T, Veneziani F, Petrucci F, Vannucchi V, Bertini L, Luchinat C, Landini G, Turano P (2022b) Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients. PLoS Pathog 18:e1010443. https:\/\/doi.org\/10.1371\/journal.ppat.1010443","journal-title":"PLoS Pathog"},{"key":"618_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.nbt.2019.04.004","volume":"52","author":"V Ghini","year":"2019","unstructured":"Ghini V, Quaglio D, Luchinat C, Turano P (2019) NMR for sample quality assessment in metabolomics. N Biotechnol 52:25\u201334. https:\/\/doi.org\/10.1016\/j.nbt.2019.04.004","journal-title":"N Biotechnol"},{"key":"618_CR50","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1021\/acs.jproteome.5b00275","volume":"14","author":"V Ghini","year":"2015","unstructured":"Ghini V, Saccenti E, Tenori L, Assfalg M, Luchinat C (2015a) Allostasis and resilience of the human individual metabolic phenotype. J Proteome Res 14:2951\u20132962. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00275","journal-title":"J Proteome Res"},{"key":"618_CR51","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1039\/D1DT00750E","volume":"50","author":"V Ghini","year":"2021","unstructured":"Ghini V, Senzacqua T, Massai L, Gamberi T, Messori L, Turano P (2021) NMR reveals the metabolic changes induced by auranofin in A2780 cancer cells: evidence for glutathione dysregulation. Dalton Trans 50:6349\u20136355. https:\/\/doi.org\/10.1039\/D1DT00750E","journal-title":"Dalton Trans"},{"key":"618_CR52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/metabo10100396","volume":"10","author":"V Ghini","year":"2020","unstructured":"Ghini V, Tenori L, Pane M, Amoruso A, Marroncini G, Squarzanti DF, Azzimonti B, Rolla R, Savoia P, Tarocchi M, Galli A, Luchinat C (2020b) Effects of probiotics administration on human metabolic phenotype. Metabolites 10:396. https:\/\/doi.org\/10.3390\/metabo10100396","journal-title":"Metabolites"},{"key":"618_CR53","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s11306-015-0832-5","volume":"11","author":"V Ghini","year":"2015","unstructured":"Ghini V, Unger FT, Tenori L, Turano P, Juhl H, David KA (2015b) Metabolomics profiling of pre-and post-anesthesia plasma samples of colorectal patients obtained via Ficoll separation. Metabolomics 11:1769\u20131778. https:\/\/doi.org\/10.1007\/s11306-015-0832-5","journal-title":"Metabolomics"},{"key":"618_CR54","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14737159.2016.1198258","volume":"16","author":"N Ghosh","year":"2016","unstructured":"Ghosh N, Dutta M, Singh B, Banerjee R, Bhattacharyya P, Chaudhury K (2016) Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update. Expert Rev Mol Diagn 16:897\u2013913. https:\/\/doi.org\/10.1080\/14737159.2016.1198258","journal-title":"Expert Rev Mol Diagn"},{"key":"618_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","volume":"13","author":"L Gianni","year":"2012","unstructured":"Gianni L, Pienkowski T, Im Y-H, Roman L, Tseng L-M, Liu M-C, Lluch A, Staroslawska E, de la Haba-Rodriguez J, Im S-A, Pedrini JL, Poirier B, Morandi P, Semiglazov V, Srimuninnimit V, Bianchi G, Szado T, Ratnayake J, Ross G, Valagussa P (2012) Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial. Lancet Oncol 13:25\u201332. https:\/\/doi.org\/10.1016\/S1470-2045(11)70336-9","journal-title":"Lancet Oncol"},{"key":"618_CR502","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1365-2893.2009.01252.x","volume":"17","author":"MGG Godoy","year":"2010","unstructured":"Godoy MGG, Lopes EPA, Silva RO, Hallwass F, Koury LCA, Moura IM, Gon\u00e7alves SMC, Simas AM (2010) Hepatitis C virus infection diagnosis using metabonomics. J Viral Hepat 17:854\u2013858. https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01252.x","journal-title":"J Viral Hepat"},{"key":"618_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3945\/ajcn.115.110536","volume":"102","author":"E Gralka","year":"2015","unstructured":"Gralka E, Luchinat C, Tenori L, Ernst B, Thurnheer M, Schultes B (2015) Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner. Am J Clin Nutr 102:1313\u20131322. https:\/\/doi.org\/10.3945\/ajcn.115.110536","journal-title":"Am J Clin Nutr"},{"key":"618_CR57","volume-title":"Metabolomics, metabonomics and metabolite profiling","author":"WJ Griffiths","year":"2008","unstructured":"Griffiths WJ (2008) Metabolomics, metabonomics and metabolite profiling. RSC Publishing"},{"key":"618_CR58","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.clcc.2019.01.003","volume":"18","author":"SY Guraya","year":"2019","unstructured":"Guraya SY (2019) Pattern, stage, and time of recurrent colorectal cancer after curative surgery. Clin Colorectal Cancer 18:e223\u2013e228. https:\/\/doi.org\/10.1016\/j.clcc.2019.01.003","journal-title":"Clin Colorectal Cancer"},{"key":"618_CR59","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.21037\/atm.2018.09.31","volume":"6","author":"T Hamada","year":"2018","unstructured":"Hamada T, Kosumi K, Nakai Y, Koike K (2018) Surrogate study endpoints in the era of cancer immunotherapy. Ann Transl Med 6:S27. https:\/\/doi.org\/10.21037\/atm.2018.09.31","journal-title":"Ann Transl Med"},{"key":"618_CR60","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-16-1153","volume":"23","author":"CD Hart","year":"2017","unstructured":"Hart CD, Vignoli A, Tenori L, Uy GL, To TV, Adebamowo C, Hossain SM, Biganzoli L, Risi E, Love RR, Luchinat C, Di Leo A (2017) Serum metabolomic profiles identify ER-positive early breast cancer patients at increased risk of disease recurrence in a multicenter population. Clin Cancer Res 23:1422\u20131431. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1153","journal-title":"Clin Cancer Res"},{"key":"618_CR61","doi-asserted-by":"publisher","first-page":"133501","DOI":"10.1172\/jci.insight.133501","volume":"5","author":"R Hatae","year":"2020","unstructured":"Hatae R, Chamoto K, Kim YH, Sonomura K, Taneishi K, Kawaguchi S, Yoshida H, Ozasa H, Sakamori Y, Akrami M, Fagarasan S, Masuda I, Okuno Y, Matsuda F, Hirai T, Honjo T (2020) Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy. JCI Insight 5:133501. https:\/\/doi.org\/10.1172\/jci.insight.133501","journal-title":"JCI Insight"},{"key":"618_CR62","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim D-W, Felip E, P\u00e9rez-Gracia JL, Han J-Y, Molina J, Kim J-H, Arvis CD, Ahn M-J, Majem M, Fidler MJ, de Castro G, Garrido M, Lubiniecki GM, Shentu Y, Im E, Dolled-Filhart M, Garon EB (2016) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 387:1540\u20131550. https:\/\/doi.org\/10.1016\/S0140-6736(15)01281-7","journal-title":"Lancet"},{"key":"618_CR63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Wu Y-L, Paz-Ares L (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389:299\u2013311. https:\/\/doi.org\/10.1016\/S0140-6736(16)30958-8","journal-title":"Lancet"},{"key":"618_CR64","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature06882","volume":"453","author":"E Holmes","year":"2008","unstructured":"Holmes E, Loo RL, Stamler J, Bictash M, Yap IKS, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453:396\u2013400. https:\/\/doi.org\/10.1038\/nature06882","journal-title":"Nature"},{"key":"618_CR65","unstructured":"ISO 23118:2021. Molecular in vitro diagnostic examinations \u2013 specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma. https:\/\/www.iso.org\/standard\/74605.html"},{"key":"618_CR66","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1021\/acs.jproteome.7b00859","volume":"17","author":"L Jiang","year":"2018","unstructured":"Jiang L, Lee SC, Ng TC (2018) Pharmacometabonomics analysis reveals serum formate and acetate potentially associated with varying response to gemcitabine-carboplatin chemotherapy in metastatic breast cancer patients. J Proteome Res 17:1248\u20131257. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00859","journal-title":"J Proteome Res"},{"key":"618_CR67","doi-asserted-by":"publisher","first-page":"83570","DOI":"10.18632\/oncotarget.18784","volume":"8","author":"E Jobard","year":"2017","unstructured":"Jobard E, Tr\u00e9dan O, Bachelot T, Vigneron AM, A\u00eft-Oukhatar CM, Arnedos M, Rios M, Bonneterre J, Di\u00e9ras V, Jimenez M, Merlin J-L, Campone M, Elena-Herrmann B (2017) Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients. Oncotarget 8:83570\u201383584. https:\/\/doi.org\/10.18632\/oncotarget.18784","journal-title":"Oncotarget"},{"key":"618_CR68","doi-asserted-by":"publisher","first-page":"e63033","DOI":"10.7554\/eLife.63033","volume":"10","author":"H Julkunen","year":"2021","unstructured":"Julkunen H, Cicho\u0144ska A, Slagboom PE, W\u00fcrtz P (2021) Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife 10:e63033. https:\/\/doi.org\/10.7554\/eLife.63033","journal-title":"Elife"},{"key":"618_CR69","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/clpt.2013.217","volume":"95","author":"R Kaddurah-Daouk","year":"2014","unstructured":"Kaddurah-Daouk R, Weinshilboum RM, Pharmacometabolomics Research Network (2014) Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther 95:154\u2013167. https:\/\/doi.org\/10.1038\/clpt.2013.217","journal-title":"Clin Pharmacol Ther"},{"key":"618_CR70","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1021\/acs.jproteome.0c00519","volume":"19","author":"T Kimhofer","year":"2020","unstructured":"Kimhofer T, Lodge S, Whiley L, Gray N, Loo RL, Lawler NG, Nitschke P, Bong S-H, Morrison DL, Begum S, Richards T, Yeap BB, Smith C, Smith KCG, Holmes E, Nicholson JK (2020) Integrative modelling of quantitative plasma lipoprotein, metabolic and amino acid data reveals a multi-organ pathological signature of SARS-CoV-2 infection. J Proteome Res 19:4442\u20134454. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00519","journal-title":"J Proteome Res"},{"key":"618_CR71","first-page":"629","volume":"72","author":"A Klupczy\u0144ska","year":"2015","unstructured":"Klupczy\u0144ska A, Derezi\u0144ski P, Kokot ZJ (2015) Metabolomics in medical sciences \u2013 trends, challenges and perspectives. Acta Pol Pharm 72:629\u2013641","journal-title":"Acta Pol Pharm"},{"key":"618_CR72","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1183\/09031936.00072408","volume":"32","author":"G de Laurentiis","year":"2008","unstructured":"de Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, Motta A, Sofia M (2008) Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J 32:1175\u20131183. https:\/\/doi.org\/10.1183\/09031936.00072408","journal-title":"Eur Respir J"},{"key":"618_CR73","doi-asserted-by":"publisher","first-page":"33278","DOI":"10.18632\/oncotarget.26022","volume":"9","author":"G Le Gall","year":"2018","unstructured":"Le Gall G, Guttula K, Kellingray L, Tett AJ, ten Hoopen R, Kemsley KE, Savva GM, Ibrahim A, Narbad A (2018) Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls. Oncotarget 9:33278\u201333289. https:\/\/doi.org\/10.18632\/oncotarget.26022","journal-title":"Oncotarget"},{"key":"618_CR74","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyx271","volume":"47","author":"L L\u00e9cuyer","year":"2018","unstructured":"L\u00e9cuyer L, Victor Bala A, Deschasaux M, Bouchemal N, Nawfal Triba M, Vasson M-P, Rossary A, Demidem A, Galan P, Hercberg S, Partula V, Le Moyec L, Srour B, Fiolet T, Latino-Martel P, Kesse-Guyot E, Savarin P, Touvier M (2018) NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer. Int J Epidemiol 47:484\u2013494. https:\/\/doi.org\/10.1093\/ije\/dyx271","journal-title":"Int J Epidemiol"},{"key":"618_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/13547500500094034","volume":"10","author":"EM Lenz","year":"2005","unstructured":"Lenz EM, Bright J, Knight R, Westwood FR, Davies D, Major H, Wilson ID (2005) Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 10:173\u2013187. https:\/\/doi.org\/10.1080\/13547500500094034","journal-title":"Biomarkers"},{"key":"618_CR76","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0731-7085(03)00410-2","volume":"33","author":"EM Lenz","year":"2003","unstructured":"Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AFP (2003) A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33:1103\u20131115. https:\/\/doi.org\/10.1016\/S0731-7085(03)00410-2","journal-title":"J Pharm Biomed Anal"},{"key":"618_CR77","first-page":"1431","volume":"60","author":"HJ Lerner","year":"1976","unstructured":"Lerner HJ, Band PR, Israel L, Leung BS (1976) Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer. Cancer Treat Rep 60:1431\u20131435","journal-title":"Cancer Treat Rep"},{"key":"618_CR78","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3389\/fphar.2019.01175","volume":"10","author":"C Li","year":"2019","unstructured":"Li C, Li Z, Zhang T, Wei P, Li N, Zhang W, Ding X, Li J (2019) 1H NMR-based metabolomics reveals the antitumor mechanisms of triptolide in BALB\/c mice bearing CT26 Tumors. Front Pharmacol 10:1175. https:\/\/doi.org\/10.3389\/fphar.2019.01175","journal-title":"Front Pharmacol"},{"key":"618_CR79","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3892\/or.2017.5954","volume":"38","author":"Y Li","year":"2017","unstructured":"Li Y, Wang C, Li D, Deng P, Shao X, Hu J, Liu C, Jie H, Lin Y, Li Z, Qian X, Zhang H, Zhao Y (2017) 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice. Oncol Rep 38:3044\u20133054. https:\/\/doi.org\/10.3892\/or.2017.5954","journal-title":"Oncol Rep"},{"key":"618_CR80","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ijc.32190","volume":"145","author":"Y Lin","year":"2019","unstructured":"Lin Y, Ma C, Bezabeh T, Wang Z, Liang J, Huang Y, Zhao J, Liu X, Ye W, Tang W, Ouyang T, Wu R (2019) 1 H NMR-based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples. Int J Cancer 145:1679\u20131689. https:\/\/doi.org\/10.1002\/ijc.32190","journal-title":"Int J Cancer"},{"key":"618_CR81","doi-asserted-by":"publisher","first-page":"29454","DOI":"10.18632\/oncotarget.8762","volume":"7","author":"Y Lin","year":"2016","unstructured":"Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R (2016) NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget 7:29454\u201329464. https:\/\/doi.org\/10.18632\/oncotarget.8762","journal-title":"Oncotarget"},{"key":"618_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0041-008X(02)00079-0","volume":"187","author":"JC Lindon","year":"2003","unstructured":"Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG, Laursen SM, Tymiak A, Car BD, Lehman-McKeeman L, Colet J-M, Loukaci A, Thomas C (2003) Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187:137\u2013146. https:\/\/doi.org\/10.1016\/S0041-008X(02)00079-0","journal-title":"Toxicol Appl Pharmacol"},{"key":"618_CR83","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/acs.jproteome.0c00876","volume":"20","author":"S Lodge","year":"2021","unstructured":"Lodge S, Nitschke P, Kimhofer T, Coudert JD, Begum S, Bong S-H, Richards T, Edgar D, Raby E, Spraul M, Schaefer H, Lindon JC, Loo RL, Holmes E, Nicholson JK (2021) NMR spectroscopic windows on the systemic effects of SARS-CoV-2 infection on plasma lipoproteins and metabolites in relation to circulating cytokines. J Proteome Res 20:1382\u20131396. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00876","journal-title":"J Proteome Res"},{"key":"618_CR84","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ajcn\/84.3.531","volume":"84","author":"C Marianne","year":"2006","unstructured":"Marianne C, Walsh LB (2006) Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 84:531\u2013539. https:\/\/doi.org\/10.1093\/ajcn\/84.3.531","journal-title":"Am J Clin Nutr"},{"key":"618_CR85","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/cancers13020314","volume":"13","author":"J M\u00e1rquez","year":"2021","unstructured":"M\u00e1rquez J, Mat\u00e9s JM (2021) Tumor metabolome: therapeutic opportunities targeting cancer metabolic reprogramming. Cancers (Basel) 13:314. https:\/\/doi.org\/10.3390\/cancers13020314","journal-title":"Cancers (Basel)"},{"key":"618_CR86","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/S1470-2045(17)30717-9","volume":"18","author":"M Martin","year":"2017","unstructured":"Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Toma\u0161evi\u0107 Z, Denduluri N, \u0160eparovi\u0107 R, Gokmen E, Bashford A, Ruiz Borrego M, Kim S-B, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A, ExteNET Study Group (2017) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 18:1688\u20131700. https:\/\/doi.org\/10.1016\/S1470-2045(17)30717-9","journal-title":"Lancet Oncol"},{"key":"618_CR87","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1021\/acs.jproteome.1c00458","volume":"20","author":"R Masuda","year":"2021","unstructured":"Masuda R, Lodge S, Nitschke P, Spraul M, Schaefer H, Bong S-H, Kimhofer T, Hall D, Loo RL, Bizkarguenaga M, Bruzzone C, Gil-Redondo R, Embade N, Mato JM, Holmes E, Wist J, Millet O, Nicholson JK (2021) Integrative modeling of plasma metabolic and lipoprotein biomarkers of SARS-CoV-2 infection in Spanish and Australian COVID-19 patient cohorts. J Proteome Res 20:4139\u20134152. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00458","journal-title":"J Proteome Res"},{"key":"618_CR88","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ctrv.2018.04.012","volume":"67","author":"A McCartney","year":"2018","unstructured":"McCartney A, Vignoli A, Biganzoli L, Love R, Tenori L, Luchinat C, Di Leo A (2018) Metabolomics in breast cancer: a decade in review. Cancer Treat Rev 67:88\u201396. https:\/\/doi.org\/10.1016\/j.ctrv.2018.04.012","journal-title":"Cancer Treat Rev"},{"key":"618_CR89","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.breast.2017.06.021","volume":"34","author":"A McCartney","year":"2017","unstructured":"McCartney A, Vignoli A, Hart C, Tenori L, Luchinat C, Biganzoli L, Di Leo A (2017) De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancer. Breast 34:S13\u2013S18. https:\/\/doi.org\/10.1016\/j.breast.2017.06.021","journal-title":"Breast"},{"key":"618_CR90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41523-019-0123-9","volume":"5","author":"A McCartney","year":"2019","unstructured":"McCartney A, Vignoli A, Tenori L, Fornier M, Rossi L, Risi E, Luchinat C, Biganzoli L, Di Leo A (2019) Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification. NPJ Br Cancer 5:26. https:\/\/doi.org\/10.1038\/s41523-019-0123-9","journal-title":"NPJ Br Cancer"},{"key":"618_CR91","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1001\/archsurg.2011.134","volume":"146","author":"RI Meijer","year":"2011","unstructured":"Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Smulders YM (2011) Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg 146:744\u2013750. https:\/\/doi.org\/10.1001\/archsurg.2011.134","journal-title":"Arch Surg"},{"key":"618_CR92","doi-asserted-by":"publisher","first-page":"e1009243","DOI":"10.1371\/journal.ppat.1009243","volume":"17","author":"G Meoni","year":"2021","unstructured":"Meoni G, Ghini V, Maggi L, Vignoli A, Mazzoni A, Salvati L, Capone M, Vanni A, Tenori L, Fontanari P, Lavorini F, Peris A, Bartoloni A, Liotta F, Cosmi L, Luchinat C, Annunziato F, Turano P (2021) Metabolomic\/lipidomic profiling of COVID-19 and individual response to tocilizumab. PLoS Pathog 17:e1009243. https:\/\/doi.org\/10.1371\/journal.ppat.1009243","journal-title":"PLoS Pathog"},{"key":"618_CR93","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1038\/s41598-019-40028-4","volume":"9","author":"G Meoni","year":"2019","unstructured":"Meoni G, Lorini S, Monti M, Madia F, Corti G, Luchinat C, Zignego AL, Tenori L, Gragnani L (2019) The metabolic fingerprints of HCV and HBV infections studied by nuclear magnetic resonance spectroscopy. Sci Rep 9:4128. https:\/\/doi.org\/10.1038\/s41598-019-40028-4","journal-title":"Sci Rep"},{"key":"618_CR94","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/nbm.1345","volume":"22","author":"D Monle\u00f3n","year":"2009","unstructured":"Monle\u00f3n D, Morales JM, Barrasa A, L\u00f3pez JA, V\u00e1zquez C, Celda B (2009) Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed 22:342\u2013348. https:\/\/doi.org\/10.1002\/nbm.1345","journal-title":"NMR Biomed"},{"key":"618_CR95","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fphar.2018.00258","volume":"9","author":"P Montuschi","year":"2018","unstructured":"Montuschi P, Santini G, Mores N, Vignoli A, Macagno F, Shohreh R, Tenori L, Zini G, Fuso L, Mondino C, Di Natale C, D\u2019Amico A, Barnes PJ, Higenbottam T (2018) BREATHOMICS for ASSESSING the effects of treatment and withdrawal with inhaled beclomethasone\/formoterol in patients with COPD. Front Pharmacol 9:258. https:\/\/doi.org\/10.3389\/fphar.2018.00258","journal-title":"Front Pharmacol"},{"key":"618_CR96","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1183\/09031936.00036411","volume":"39","author":"A Motta","year":"2012","unstructured":"Motta A, Paris D, Melck D, de Laurentiis G, Maniscalco M, Sofia M, Montuschi P (2012) Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur Respir J 39:498\u2013500. https:\/\/doi.org\/10.1183\/09031936.00036411","journal-title":"Eur Respir J"},{"key":"618_CR97","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3748\/wjg.v26.i20.2514","volume":"26","author":"G Nannini","year":"2020","unstructured":"Nannini G, Meoni G, Amedei A, Tenori L (2020) Metabolomics profile in gastrointestinal cancers: update and future perspectives. World J Gastroenterol 26:2514\u20132532. https:\/\/doi.org\/10.3748\/wjg.v26.i20.2514","journal-title":"World J Gastroenterol"},{"key":"618_CR98","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.3748\/wjg.v27.i38.6430","volume":"27","author":"G Nannini","year":"2021","unstructured":"Nannini G, Meoni G, Tenori L, Ringressi MN, Taddei A, Niccolai E, Baldi S, Russo E, Luchinat C, Amedei A (2021) Fecal metabolomic profiles: a comparative study of patients with colorectal cancer vs adenomatous polyps. World J Gastroenterol 27:6430\u20136441. https:\/\/doi.org\/10.3748\/wjg.v27.i38.6430","journal-title":"World J Gastroenterol"},{"key":"618_CR99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11306-020-01767-y","volume":"17","author":"HTT Nguyen","year":"2021","unstructured":"Nguyen HTT, Wimmer R, Le VQ, Krarup HB (2021) Metabolic fingerprint of progression of chronic hepatitis B: changes in the metabolome and novel diagnostic possibilities. Metabolomics 17:16. https:\/\/doi.org\/10.1007\/s11306-020-01767-y","journal-title":"Metabolomics"},{"key":"618_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrd728","volume":"1","author":"JK Nicholson","year":"2002","unstructured":"Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153\u2013161. https:\/\/doi.org\/10.1038\/nrd728","journal-title":"Nat Rev Drug Discov"},{"key":"618_CR101","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fmolb.2021.678753","volume":"8","author":"X Nie","year":"2021","unstructured":"Nie X, Xia L, Gao F, Liu L, Yang Y, Chen Y, Duan H, Yao Y, Chen Z, Lu S, Wang Y, Yang C (2021) Serum metabolite biomarkers predictive of response to PD-1 blockade therapy in non-small cell lung cancer. Front Mol Biosci 8:472. https:\/\/doi.org\/10.3389\/fmolb.2021.678753","journal-title":"Front Mol Biosci"},{"key":"618_CR102","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1053\/gast.2002.30983","volume":"122","author":"M Okuda","year":"2002","unstructured":"Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366\u2013375. https:\/\/doi.org\/10.1053\/gast.2002.30983","journal-title":"Gastroenterology"},{"key":"618_CR103","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3945\/ajcn.110.000950","volume":"93","author":"A O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan A, Gibney MJ, Brennan L (2011) Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 93:314\u2013321. https:\/\/doi.org\/10.3945\/ajcn.110.000950","journal-title":"Am J Clin Nutr"},{"key":"618_CR104","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K (2011) Heterogeneity in breast cancer. J Clin Invest 121:3786\u20133788. https:\/\/doi.org\/10.1172\/JCI60534","journal-title":"J Clin Invest"},{"key":"618_CR105","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","volume":"33","author":"MA Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD (2015) Immune checkpoint blockade in cancer therapy. J Clin Oncol 33:1974\u20131982. https:\/\/doi.org\/10.1200\/JCO.2014.59.4358","journal-title":"J Clin Oncol"},{"key":"618_CR106","doi-asserted-by":"publisher","first-page":"209","DOI":"10.14573\/altex.2013.2.209","volume":"30","author":"T Ramirez","year":"2013","unstructured":"Ramirez T, Daneshian M, Kamp H, Bois FY, Clench MR, Coen M, Donley B, Fischer SM, Ekman DR, Fabian E, Guillou C, Heuer J, Hogberg HT, Jungnickel H, Keun HC, Krennrich G, Krupp E, Luch A, Noor F, Peter E, Riefke B, Seymour M, Skinner N, Smirnova L, Verheij E, Wagner S, Hartung T, van Ravenzwaay B, Leist M (2013) Metabolomics in toxicology and preclinical research. ALTEX 30:209\u2013225. https:\/\/doi.org\/10.14573\/altex.2013.2.209","journal-title":"ALTEX"},{"key":"618_CR107","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3389\/fmolb.2021.742859","volume":"8","author":"K Resendiz-Acevedo","year":"2021","unstructured":"Resendiz-Acevedo K, Garc\u00eda-Aguilera ME, Esturau-Escofet N, Ruiz-Azuara L (2021) 1H -NMR metabolomics study of the effect of cisplatin and CasiopeinaIIgly on MDA-MB-231 breast tumor cells. Front Mol Biosci 8:1135. https:\/\/doi.org\/10.3389\/fmolb.2021.742859","journal-title":"Front Mol Biosci"},{"key":"618_CR108","doi-asserted-by":"publisher","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","volume":"372","author":"M Ringehan","year":"2017","unstructured":"Ringehan M, McKeating JA, Protzer U (2017) Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci 372:20160274. https:\/\/doi.org\/10.1098\/rstb.2016.0274","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"618_CR109","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","volume":"389","author":"A Rittmeyer","year":"2017","unstructured":"Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee J-S, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR, OAK Study Group (2017) Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet 389:255\u2013265. https:\/\/doi.org\/10.1016\/S0140-6736(16)32517-X","journal-title":"Lancet"},{"key":"618_CR110","doi-asserted-by":"publisher","first-page":"602369","DOI":"10.3389\/fphar.2020.602369","volume":"11","author":"MS Rocca","year":"2020","unstructured":"Rocca MS, Vignoli A, Tenori L, Ghezzi M, De Rocco Ponce M, Vatsellas G, Thanos D, Padrini R, Foresta C, De Toni L (2020) Evaluation of serum\/urine genomic and metabolomic profiles to improve the adherence to sildenafil therapy in patients with erectile dysfunction. Front Pharmacol 11:602369. https:\/\/doi.org\/10.3389\/fphar.2020.602369","journal-title":"Front Pharmacol"},{"key":"618_CR111","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1038\/s41598-018-37525-3","volume":"9","author":"R Saborano","year":"2019","unstructured":"Saborano R, Eraslan Z, Roberts J, Khanim FL, Lalor PF, Reed MAC, G\u00fcnther UL (2019) A framework for tracer-based metabolism in mammalian cells by NMR. Sci Rep 9:2520. https:\/\/doi.org\/10.1038\/s41598-018-37525-3","journal-title":"Sci Rep"},{"key":"618_CR112","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1021\/acs.analchem.1c04360","volume":"94","author":"AM Salmer\u00f3n","year":"2022","unstructured":"Salmer\u00f3n AM, Trist\u00e1n AI, Abreu AC, Fern\u00e1ndez I (2022) Serum colorectal cancer biomarkers unraveled by NMR metabolomics: past, present, and future. Anal Chem 94:417\u2013430. https:\/\/doi.org\/10.1021\/acs.analchem.1c04360","journal-title":"Anal Chem"},{"key":"618_CR113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40169-016-0109-2","volume":"5","author":"MO Sarfaraz","year":"2016","unstructured":"Sarfaraz MO, Myers RP, Coffin CS, Gao Z-H, Shaheen AAM, Crotty PM, Zhang P, Vogel HJ, Weljie AM (2016) A quantitative metabolomics profiling approach for the noninvasive assessment of liver histology in patients with chronic hepatitis C. Clin Transl Med 5:33. https:\/\/doi.org\/10.1186\/s40169-016-0109-2","journal-title":"Clin Transl Med"},{"key":"618_CR114","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"618_CR115","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/metabo9110269","volume":"9","author":"CL Silva","year":"2019","unstructured":"Silva CL, Olival A, Perestrelo R, Silva P, Tom\u00e1s H, C\u00e2mara JS (2019) Untargeted urinary 1H NMR-based metabolomic pattern as a potential platform in breast cancer detection. Metabolites 9:269. https:\/\/doi.org\/10.3390\/metabo9110269","journal-title":"Metabolites"},{"key":"618_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169330","volume":"12","author":"A Singh","year":"2017","unstructured":"Singh A, Sharma RK, Chagtoo M, Agarwal G, George N, Sinha N, Godbole MM (2017) 1H NMR metabolomics reveals association of high expression of inositol 1, 4, 5 trisphosphate receptor and metabolites in breast cancer patients. PLoS One 12:e0169330. https:\/\/doi.org\/10.1371\/journal.pone.0169330","journal-title":"PLoS One"},{"key":"618_CR117","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41416-018-0357-6","volume":"120","author":"P Sirni\u00f6","year":"2019","unstructured":"Sirni\u00f6 P, V\u00e4yrynen JP, Klintrup K, M\u00e4kel\u00e4 J, Karhu T, Herzig K-H, Minkkinen I, M\u00e4kinen MJ, Karttunen TJ, Tuomisto A (2019) Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival. Br J Cancer 120:238\u2013246. https:\/\/doi.org\/10.1038\/s41416-018-0357-6","journal-title":"Br J Cancer"},{"key":"618_CR118","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/nbm.992","volume":"19","author":"B Sitter","year":"2006","unstructured":"Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS (2006) Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 19:30\u201340. https:\/\/doi.org\/10.1002\/nbm.992","journal-title":"NMR Biomed"},{"key":"618_CR119","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","volume":"365","author":"D Slamon","year":"2011","unstructured":"Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu M-C, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay M-A, Riva A, Crown J, Breast Cancer International Research Group (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365:1273\u20131283. https:\/\/doi.org\/10.1056\/NEJMoa0910383","journal-title":"N Engl J Med"},{"key":"618_CR120","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-10-1434","volume":"16","author":"CM Slupsky","year":"2010","unstructured":"Slupsky CM, Steed H, Wells T, Dabbs K, Schepansky A, Capstick V, Faught W, Sawyer MB (2010) Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin Cancer Res 16:5835\u20135841. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1434","journal-title":"Clin Cancer Res"},{"key":"618_CR121","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpba.2018.07.024","volume":"160","author":"S Suman","year":"2018","unstructured":"Suman S, Sharma RK, Kumar V, Sinha N, Shukla Y (2018) Metabolic fingerprinting in breast cancer stages through 1H NMR spectroscopy-based metabolomic analysis of plasma. J Pharm Biomed Anal 160:38\u201345. https:\/\/doi.org\/10.1016\/j.jpba.2018.07.024","journal-title":"J Pharm Biomed Anal"},{"key":"618_CR122","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"618_CR123","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","volume":"14","author":"SM Swain","year":"2013","unstructured":"Swain SM, Kim S-B, Cort\u00e9s J, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero J-M, Schneeweiss A, Knott A, Clark E, Ross G, Benyunes MC, Baselga J (2013) Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol 14:461\u2013471. https:\/\/doi.org\/10.1016\/S1470-2045(13)70130-X","journal-title":"Lancet Oncol"},{"key":"618_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2018.10.036","volume":"120","author":"PG Takis","year":"2019","unstructured":"Takis PG, Ghini V, Tenori L, Turano P, Luchinat C (2019) Uniqueness of the NMR approach to metabolomics. TRAC-Trends Anal Chem 120:115300. https:\/\/doi.org\/10.1016\/j.trac.2018.10.036","journal-title":"TRAC-Trends Anal Chem"},{"key":"618_CR125","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1021\/pr400337b","volume":"12","author":"B Tan","year":"2013","unstructured":"Tan B, Qiu Y, Zou X, Chen T, Xie G, Cheng Y, Dong T, Zhao L, Feng B, Hu X, Xu LX, Zhao A, Zhang M, Cai G, Cai S, Zhou Z, Zheng M, Zhang Y, Jia W (2013) Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res 12:3000\u20133009. https:\/\/doi.org\/10.1021\/pr400337b","journal-title":"J Proteome Res"},{"key":"618_CR126","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.18632\/oncotarget.24433","volume":"9","author":"F Tayyari","year":"2018","unstructured":"Tayyari F, Gowda GAN, Olopade OF, Berg R, Yang HH, Lee MP, Ngwa WF, Mittal SK, Raftery D, Mohammed SI (2018) Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences. Oncotarget 9:11677\u201311690. https:\/\/doi.org\/10.18632\/oncotarget.24433","journal-title":"Oncotarget"},{"key":"618_CR127","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molonc.2012.05.003","volume":"6","author":"L Tenori","year":"2012","unstructured":"Tenori L, Oakman C, Claudino WM, Bernini P, Cappadona S, Nepi S, Biganzoli L, Arbushites MC, Luchinat C, Bertini I, Di Leo A (2012) Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study. Mol Oncol 6:437\u2013444. https:\/\/doi.org\/10.1016\/j.molonc.2012.05.003","journal-title":"Mol Oncol"},{"key":"618_CR128","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molonc.2014.07.012","volume":"9","author":"L Tenori","year":"2015","unstructured":"Tenori L, Oakman C, Morris PG, Gralka E, Turner N, Cappadona S, Fornier M, Hudis C, Norton L, Luchinat C, Di Leo A (2015) Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study. Mol Oncol 9:128\u2013139. https:\/\/doi.org\/10.1016\/j.molonc.2014.07.012","journal-title":"Mol Oncol"},{"key":"618_CR129","doi-asserted-by":"publisher","first-page":"x231","DOI":"10.1093\/annonc\/mds324","volume":"23","author":"AM Thompson","year":"2012","unstructured":"Thompson AM, Moulder-Thompson SL (2012) Neoadjuvant treatment of breast cancer. Ann Oncol 23:x231\u2013x236. https:\/\/doi.org\/10.1093\/annonc\/mds324","journal-title":"Ann Oncol"},{"key":"618_CR130","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1586\/17474124.2014.945912","volume":"8","author":"P Turano","year":"2014","unstructured":"Turano P (2014) Colorectal cancer: the potential of metabolic fingerprinting. Expert Rev Gastroenterol Hepatol 8:847\u2013849. https:\/\/doi.org\/10.1586\/17474124.2014.945912","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"618_CR131","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"S Verma","year":"2012","unstructured":"Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, Pegram M, Oh D-Y, Di\u00e9ras V, Guardino E, Fang L, Lu MW, Olsen S, Blackwell K, EMILIA Study Group (2012) Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med 367:1783\u20131791. https:\/\/doi.org\/10.1056\/NEJMoa1209124","journal-title":"N Engl J Med"},{"key":"618_CR132","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/anie.201804736","volume":"58","author":"A Vignoli","year":"2019","unstructured":"Vignoli A, Ghini V, Meoni G, Licari C, Takis PG, Tenori L, Turano P, Luchinat C (2019) High-throughput metabolomics by 1D NMR. Angew Chem Int Ed 58:968\u2013994. https:\/\/doi.org\/10.1002\/anie.201804736","journal-title":"Angew Chem Int Ed"},{"key":"618_CR133","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.3390\/app112311120","volume":"11","author":"A Vignoli","year":"2021","unstructured":"Vignoli A, Mori E, Di Donato S, Malorni L, Biagioni C, Benelli M, Calamai V, Cantafio S, Parnofiello A, Baraghini M, Garzi A, Monte FD, Romagnoli D, Migliaccio I, Luchinat C, Tenori L, Biganzoli L (2021a) Exploring serum NMR-based metabolomic fingerprint of colorectal cancer patients: effects of surgery and possible associations with cancer relapse. Appl Sci 11:11120. https:\/\/doi.org\/10.3390\/app112311120","journal-title":"Appl Sci"},{"key":"618_CR134","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/cancers12020314","volume":"12","author":"A Vignoli","year":"2020","unstructured":"Vignoli A, Muraro E, Miolo G, Tenori L, Turano P, Di Gregorio E, Steffan A, Luchinat C, Corona G (2020a) Effect of Estrogen receptor status on circulatory immune and metabolomics profiles of HER2-positive breast cancer patients enrolled for neoadjuvant targeted chemotherapy. Cancers 12:314. https:\/\/doi.org\/10.3390\/cancers12020314","journal-title":"Cancers"},{"key":"618_CR135","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1021\/acs.jproteome.8b00849","volume":"18","author":"A Vignoli","year":"2019","unstructured":"Vignoli A, Orlandini B, Tenori L, Biagini MR, Milani S, Renzi D, Luchinat C, Calabr\u00f2 AS (2019) Metabolic signature of primary biliary cholangitis and its comparison with celiac disease. J Proteome Res 18:1228\u20131236. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00849","journal-title":"J Proteome Res"},{"key":"618_CR136","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.3390\/ijms22094687","volume":"22","author":"A Vignoli","year":"2021","unstructured":"Vignoli A, Risi E, McCartney A, Migliaccio I, Moretti E, Malorni L, Luchinat C, Biganzoli L, Tenori L (2021b) Precision oncology via NMR-based metabolomics: a review on breast cancer. Int J Mol Sci 22:4687. https:\/\/doi.org\/10.3390\/ijms22094687","journal-title":"Int J Mol Sci"},{"key":"618_CR137","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1021\/acs.jproteome.9b00345","volume":"19","author":"A Vignoli","year":"2020","unstructured":"Vignoli A, Santini G, Tenori L, Macis G, Mores N, Macagno F, Pagano F, Higenbottam T, Luchinat C, Montuschi P (2020b) NMR-based metabolomics for the assessment of inhaled pharmacotherapy in chronic obstructive pulmonary disease patients. J Proteome Res 19:64\u201374. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00345","journal-title":"J Proteome Res"},{"key":"618_CR138","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1021\/acs.jproteome.1c00935","volume":"21","author":"A Vignoli","year":"2022","unstructured":"Vignoli A, Tenori L, Morsiani C, Turano P, Capri M, Luchinat C (2022) Serum or plasma (and which plasma), that is the question. J Proteome Res 21:1061\u20131072. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00935","journal-title":"J Proteome Res"},{"key":"618_CR139","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang C-S, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, W\u00fclfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE, Katherine Investigators (2019) Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380:617\u2013628. https:\/\/doi.org\/10.1056\/NEJMoa1814017","journal-title":"N Engl J Med"},{"key":"618_CR140","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1703643","volume":"377","author":"G von Minckwitz","year":"2017","unstructured":"von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J, Aphinity Steering Committee and Investigators (2017) Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer. N Engl J Med 377:122\u2013131. https:\/\/doi.org\/10.1056\/NEJMoa1703643","journal-title":"N Engl J Med"},{"key":"618_CR141","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12263-014-0441-3","volume":"10","author":"S Wallner-Liebmann","year":"2015","unstructured":"Wallner-Liebmann S, Gralka E, Tenori L, Konrad M, Hofmann P, Dieber-Rotheneder M, Turano P, Luchinat C, Zatloukal K (2015) The impact of free or standardized lifestyle and urine sampling protocol on metabolome recognition accuracy. Genes Nutr 10:441. https:\/\/doi.org\/10.1007\/s12263-014-0441-3","journal-title":"Genes Nutr"},{"key":"618_CR142","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1021\/acs.jproteome.5b01060","volume":"15","author":"S Wallner-Liebmann","year":"2016","unstructured":"Wallner-Liebmann S, Tenori L, Mazzoleni A, Dieber-Rotheneder M, Konrad M, Hofmann P, Luchinat C, Turano P, Zatloukal K (2016) Individual human metabolic phenotype analyzed by (1)H NMR of saliva samples. J Proteome Res 15:1787\u20131793. https:\/\/doi.org\/10.1021\/acs.jproteome.5b01060","journal-title":"J Proteome Res"},{"key":"618_CR143","doi-asserted-by":"publisher","first-page":"e65675","DOI":"10.1371\/journal.pone.0065675","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Tang Y, Liu S, Mao S, Ling Y, Liu D, He X, Wang X (2013) Metabonomic profiling of serum and urine by 1H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PLoS One 8:e65675. https:\/\/doi.org\/10.1371\/journal.pone.0065675","journal-title":"PLoS One"},{"key":"618_CR144","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s40495-016-0079-5","volume":"3","author":"P Wang","year":"2017","unstructured":"Wang P, Shehu AI, Ma X (2017) The opportunities of metabolomics in drug safety evaluation. Curr Pharmacol Rep 3:10\u201315. https:\/\/doi.org\/10.1007\/s40495-016-0079-5","journal-title":"Curr Pharmacol Rep"},{"key":"618_CR145","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molonc.2012.10.003","volume":"7","author":"S Wei","year":"2013","unstructured":"Wei S, Liu L, Zhang J, Bowers J, Gowda GAN, Seeger H, Fehm T, Neubauer HJ, Vogel U, Clare SE, Raftery D (2013) Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol Oncol 7:297\u2013307. https:\/\/doi.org\/10.1016\/j.molonc.2012.10.003","journal-title":"Mol Oncol"},{"key":"618_CR146","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00254419","volume":"3","author":"RG Wiggans","year":"1979","unstructured":"Wiggans RG, Woolley PV, Smythe T, Hoth D, Macdonald JS, Green L, Schein PS (1979) Phase-II trial of tamoxifen in advanced breast cancer. Cancer Chemother Pharmacol 3:45\u201348. https:\/\/doi.org\/10.1007\/BF00254419","journal-title":"Cancer Chemother Pharmacol"},{"key":"618_CR147","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3945\/ajcn.2009.28234","volume":"90","author":"JH Winnike","year":"2009","unstructured":"Winnike JH, Busby MG, Watkins PB, O\u2019Connell TM (2009) Effects of a prolonged standardized diet on normalizing the human metabolome. Am J Clin Nutr 90:1496\u20131501. https:\/\/doi.org\/10.3945\/ajcn.2009.28234","journal-title":"Am J Clin Nutr"},{"key":"618_CR501","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ebiom.2015.05.022","volume":"2","author":"DS Wishart","year":"2015","unstructured":"Wishart DS (2015) Is cancer a genetic disease or a metabolic disease? EBioMedicine 2:478\u2013479. https:\/\/doi.org\/10.1016\/j.ebiom.2015.05.022","journal-title":"EBioMedicine"},{"key":"618_CR148","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/metabo10050173","volume":"10","author":"W Wojtowicz","year":"2020","unstructured":"Wojtowicz W, Wr\u00f3bel A, Pyziak K, Tarkowski R, Balcerzak A, B\u0119benek M, M\u0142ynarz P (2020) Evaluation of MDA-MB-468 cell culture media analysis in predicting triple-negative breast cancer patient sera metabolic profiles. Metabolites 10:173. https:\/\/doi.org\/10.3390\/metabo10050173","journal-title":"Metabolites"},{"key":"618_CR149","volume-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact: web annex 1: key data at a glance","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021) Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact: web annex 1: key data at a glance. World Health Organization, Geneva"},{"key":"618_CR150","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P (2021) Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 14:101174. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174","journal-title":"Transl Oncol"},{"key":"618_CR151","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/nrdp.2016.3","volume":"2","author":"FA Yafi","year":"2016","unstructured":"Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, Maggi M, Nelson CJ, Parish S, Salonia A, Tan R, Mulhall JP, Hellstrom WJG (2016) Erectile dysfunction. Nat Rev Dis Primers 2:16003. https:\/\/doi.org\/10.1038\/nrdp.2016.3","journal-title":"Nat Rev Dis Primers"},{"key":"618_CR152","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s11306-015-0808-5","volume":"11","author":"A Z\u0105bek","year":"2015","unstructured":"Z\u0105bek A, Stanimirova I, Deja S, Barg W, Kowal A, Korzeniewska A, Orczyk-Pawi\u0142owicz M, Baranowski D, Gdaniec Z, Jankowska R, M\u0142ynarz P (2015) Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome. Metabolomics 11:1563\u20131574. https:\/\/doi.org\/10.1007\/s11306-015-0808-5","journal-title":"Metabolomics"},{"key":"618_CR153","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.3748\/wjg.v20.i26.8646","volume":"20","author":"X Zhang","year":"2014","unstructured":"Zhang X, Zhao X-W, Liu D-B, Han C-Z, Du L-L, Jing J-X, Wang Y (2014) Lipid levels in serum and cancerous tissues of colorectal cancer patients. World J Gastroenterol 20:8646\u20138652. https:\/\/doi.org\/10.3748\/wjg.v20.i26.8646","journal-title":"World J Gastroenterol"},{"key":"618_CR154","doi-asserted-by":"publisher","unstructured":"Zhou J, Wang Y, Zhang X (2017) Metabonomics studies on serum and urine of patients with breast cancer using 1 H-NMR spectroscopy. Oncotarget 5. https:\/\/doi.org\/10.18632\/oncotarget.16210","DOI":"10.18632\/oncotarget.16210"},{"key":"618_CR155","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1021\/pr500494u","volume":"13","author":"J Zhu","year":"2014","unstructured":"Zhu J, Djukovic D, Deng L, Gu H, Himmati F, Chiorean EG, Raftery D (2014) Colorectal cancer detection using targeted serum metabolic profiling. J Proteome Res 13:4120\u20134130. https:\/\/doi.org\/10.1021\/pr500494u","journal-title":"J Proteome Res"}],"container-title":["Handbook of Experimental Pharmacology","Metabolomics and Its Impact on Health and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2022_618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T15:03:23Z","timestamp":1677855803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2022_618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031268588","9783031268595"],"references-count":157,"URL":"https:\/\/doi.org\/10.1007\/164_2022_618","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}